Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,536 | 142 | 99.5% |
| Education | $13.89 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $358.78 | 10 | $0 (2024) |
| ABBVIE INC. | $336.07 | 18 | $0 (2024) |
| Lilly USA, LLC | $298.34 | 17 | $0 (2024) |
| Novo Nordisk Inc | $261.19 | 17 | $0 (2024) |
| Amgen Inc. | $182.10 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $104.77 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $88.45 | 6 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $87.69 | 6 | $0 (2024) |
| EISAI INC. | $68.86 | 3 | $0 (2022) |
| Dynavax Technologies Corporation | $65.05 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $887.30 | 44 | AstraZeneca Pharmaceuticals LP ($131.96) |
| 2023 | $663.30 | 35 | AstraZeneca Pharmaceuticals LP ($138.03) |
| 2022 | $595.20 | 38 | Lilly USA, LLC ($82.53) |
| 2021 | $403.72 | 26 | Novo Nordisk Inc ($73.77) |
All Payment Transactions
143 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: VIROLOGY | ||||||
| 12/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: UROLOGY | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Obesity | ||||||
| 11/15/2024 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: VIROLOGY | ||||||
| 10/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Hepatitis B Vaccine | ||||||
| 09/20/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Diabetes | ||||||
| 08/12/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $36.12 | General |
| Category: VTE | ||||||
| 08/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Oncology | ||||||
| 08/02/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: HIV | ||||||
| 07/30/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Iron Deficiency Anemia | ||||||
| 07/12/2024 | Melinta Therapeutics, LLC | Kimyrsa (Drug), Orbactiv, Rezzayo | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: ANTIBIOTICS | ||||||
| 07/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: PAIN | ||||||
| 06/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Endocrinology | ||||||
| 06/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 955 | 2,344 | $229,340 | $84,935 |
| 2022 | 17 | 669 | 811 | $130,225 | $40,263 |
| 2021 | 14 | 732 | 884 | $152,783 | $49,967 |
| 2020 | 11 | 701 | 849 | $135,544 | $35,437 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,140 | $31,920 | $19,926 | 62.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 150 | 150 | $39,300 | $15,630 | 39.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 52 | 52 | $34,424 | $14,701 | 42.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 196 | $51,156 | $11,896 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 117 | 176 | $31,328 | $7,384 | 23.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 43 | $15,050 | $3,651 | 24.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 35 | 35 | $5,355 | $2,518 | 47.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 171 | 260 | $4,160 | $2,177 | 52.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $5,456 | $2,003 | 36.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 56 | 56 | $1,400 | $1,372 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 53 | 54 | $1,350 | $1,323 | 98.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 13 | 13 | $2,171 | $946.61 | 43.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 51 | 91 | $2,457 | $866.32 | 35.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 13 | 15 | $1,185 | $228.91 | 19.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 24 | $1,344 | $187.54 | 14.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $792.00 | $98.45 | 12.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 11 | 12 | $492.00 | $26.40 | 5.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 108 | 108 | $28,296 | $11,443 | 40.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 152 | $39,672 | $9,313 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 162 | $28,836 | $7,392 | 25.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 44 | 44 | $7,348 | $3,091 | 42.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 17 | 17 | $5,100 | $2,232 | 43.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $4,081 | $1,493 | 36.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 50 | 50 | $1,250 | $1,226 | 98.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 51 | 100 | $2,700 | $952.00 | 35.3% |
About Shannel Millard
Shannel Millard is a Family healthcare provider based in Topeka, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/07/2016. The National Provider Identifier (NPI) number assigned to this provider is 1326404245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shannel Millard has received a total of $2,550 in payments from pharmaceutical and medical device companies, with $887.30 received in 2024. These payments were reported across 143 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($2,536).
As a Medicare-enrolled provider, Millard has provided services to 3,057 Medicare beneficiaries, totaling 4,888 services with total Medicare billing of $210,601. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Topeka, KS
- Active Since 01/07/2016
- Last Updated 01/07/2016
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1326404245
Products in Payments
- VRAYLAR (Drug) $197.49
- BREZTRI (Drug) $182.86
- FARXIGA (Drug) $175.92
- MOUNJARO (Drug) $169.41
- Rybelsus (Drug) $100.20
- Otezla (Drug) $91.00
- XIFAXAN (Drug) $87.69
- DIFICID (Drug) $84.03
- JARDIANCE (Drug) $80.86
- EVENITY (Biological) $77.21
- TRELEGY ELLIPTA (Drug) $76.14
- Heplisav-B (Drug) $65.05
- TRULICITY (Drug) $63.40
- MAVYRET (Drug) $54.80
- Ozempic (Drug) $54.42
- DOVATO (Drug) $40.48
- UBRELVY (Drug) $39.17
- NURTEC ODT (Drug) $39.12
- Vascepa (Drug) $38.50
- FLOWTRIEVER CATHETER, S (Device) $36.12
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Topeka
Tatum Toland, Aprn, APRN
Family — Payments: $88,932
Jason Crenshaw, Arnp, Fnp, ARNP, FNP
Family — Payments: $4,875
Edelis Ocasio, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $4,461
Mrs. Moshe Kincade, Aprn, APRN
Family — Payments: $3,354
Diane Wilkins, A.r.n.p, A.R.N.P
Family — Payments: $3,255
Mariah Kalma, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $2,543